HKBU | The Epoch Times

HKBU Develops New Drug With Chaenomeles Fructus to Treat Rare Diseases Approved by the United States

Myofibrillar myopathy is a rare disease that causes muscle atrophy, stiffness, respiratory muscle weakness, and symptoms such as cardiomyopathy and movement disorders. Patients usually manifest symptoms of the disease during ...

January 16, 2024BY Leo Cheung

Oral Drug With Hyodeoxycholic Acid That Helps Treat Diabetes and Fatty Liver Is Expected to Be Developed Within 5 Years: HKBU Research

Non-alcoholic fatty liver disease (NAFLD) is one of the urban syndromes. About 28 to 30 percent of adults ...

November 15, 2023BY Terence Tang

Political Cartoonist Forced to Leave Hong Kong After His Work Attracted Police Attention

A former assistant professor at the School of Visual Arts of Baptist University (HKBU) and political cartoonist has ...

January 8, 2023BY Kaworu Tsang and Harry McKenny

Senior Patients With Long-COVID to Receive Free Diagnosis and Traditional Chinese Medicine in Hong Kong

The School of Chinese Medicine at Hong Kong Baptist University (HKBU) launched a rehabilitation programme that provides free ...

September 3, 2022BY Audrey Lee

HKBU Develops F-SLOH to Treat Alzheimer’s Disease

The Hong Kong Baptist University (HKBU) has developed a multifunctional organic compound called F-SLOH, which has the potential ...

August 29, 2022BY David Chu